TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
31 juil. 2023 08h35 HE
|
Trxade Health, Inc.
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced...